Chemoinformaics analysis of 1,8-DIHYDROXY-3-CARBOXYANTHRAQUINONE
| Molecular Weight | 284.223 | nRot | 1 |
| Heavy Atom Molecular Weight | 276.159 | nRig | 19 |
| Exact Molecular Weight | 284.032 | nRing | 3 |
| Solubility: LogS | -4.092 | nHRing | 0 |
| Solubility: LogP | 3.524 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 35.1963 |
| nHD | 3 | BPOL | 10.6297 |
| QED | 0.625 |
| Synth | 2.235 |
| Natural Product Likeliness | 1.057 |
| NR-PPAR-gamma | 0.929 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.022 |
| Pgp-sub | 0.001 |
| HIA | 0.063 |
| CACO-2 | -5.232 |
| MDCK | 0.00000794 |
| BBB | 0.096 |
| PPB | 0.980936 |
| VDSS | 0.497 |
| FU | 0.0180512 |
| CYP1A2-inh | 0.371 |
| CYP1A2-sub | 0.06 |
| CYP2c19-inh | 0.033 |
| CYP2c19-sub | 0.039 |
| CYP2c9-inh | 0.481 |
| CYP2c9-sub | 0.056 |
| CYP2d6-inh | 0.114 |
| CYP2d6-sub | 0.088 |
| CYP3a4-inh | 0.126 |
| CYP3a4-sub | 0.068 |
| CL | 0.908 |
| T12 | 0.615 |
| hERG | 0.028 |
| Ames | 0.909 |
| ROA | 0.029 |
| SkinSen | 0.534 |
| Carcinogencity | 0.62 |
| EI | 0.848 |
| Respiratory | 0.069 |
| NR-Aromatase | 0.026 |
| Antiviral | Yes |
| Prediction | 0.778161 |